Patent · US Active

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

US7834012B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Zhonghua Pei · South San Francisco, US
Thomas W. von Geldern · North Chicago, US
David J. Madar · Gilbert, US
Xiaofeng Li · Plano, US
Fatima Z. Basha · Lake Forest, US
Hong Yong · Libertyville, US
Kenton L. Longenecker · Grayslake, US
Bradley Backes · San Francisco, US
Andrew S. Judd · Grayslake, US
Mathew M. Mulhern · Hainesville, US
Kent D. Stewart · Gurnee, US

Key dates

Filing date	Aug 25, 2006
Grant date	Nov 16, 2010
Priority date	—
Expiry date	Jan 30, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/16
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to compounds, which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II, as well as hyperglycemia, metabolic syndrome, hyperinsulinemia, obesity, atherosclerosis, various immunomodulatory diseases, and other diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.